01/23/2026
Two years of Braxley.
We have now reached the part in Braxley’s journey of her 2nd birthday. Two years of a little girl who is full of sass, independence, and a determination that cannot be taught. Braxley knows what she wants, isn’t afraid to let you know, and approaches the world with a confidence that stops us in our tracks. She is strong-willed, curious, and relentlessly herself—and we have no doubt that this same determination will serve her well in the life she is fighting for.
That year, we watched her push limits, insist on doing things her own way, and show us just how much fire lives inside such a small body. Those qualities—the ones that made us laugh, pause, and sometimes shake our head—are the same ones that will carry her through the hardest moments ahead.
And while today is about the look back of celebrating Braxleys 2nd birthday, it is also a reminder of why we launched Braxley the Brave and why we continue to work tirelessly to raise awareness and funds for the ACTA2 Alliance.
Children like Braxley who live with Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS) face devastating risks, including strokes, aortic dissections, lung disease, and other life-threatening complications. Tragically, many do not reach adulthood.
To change this, the ACTA2 Alliance is working alongside leading clinicians and scientists to develop therapies that could alter the course of this disease. Current research includes Nicotinamide Riboside (NR) as a potential treatment for MSMDS, as well as a gene therapy designed to correct the underlying mutation itself.
While parts of this work were expected to begin testing in children in February 2026, recent cuts to rare disease research funding have delayed progress. These delays have directly impacted Braxley and other children who urgently need these therapies now. Without additional support, these promising treatments may never reach the kids whose lives depend on them.
The impact of this work extends far beyond MSMDS. Advances in ACTA2 research may also benefit individuals affected by Marfan syndrome, Moyamoya disease, Loeys-Dietz syndrome, and even atherosclerosis.
Like any parent would, we will not stop. We will not slow down. We will not accept “later” when our child needs help now. We will continue fighting—because Braxley is already doing her part every single day.
Here’s to many more birthdays, brave girl. You are the reason we fight so hard.